Mumbai: US-returned man tests positive for Omicron; Had taken three doses of vaccine
PTI, Dec 18, 2021, 9:35 AM IST
Mumbai: A 29-year-old man who had returned from New York tested positive for Omicron variant here on Friday, the Brihanmumbai Municipal Corporation (BMC) said in a release.
Notably, the man, who has no symptoms, had taken three doses of Pfizer’s coronavirus vaccine, it added.
He tested positive for COVID-19 in a test conducted at the airport on November 9, after which his samples were sent for genome sequencing.
Two of his high-risk contacts tested negative for coronavirus, the BMC said.
”The patient has been admitted to a hospital as a precautionary measure and he has no symptoms,” the civic body said in a release.
This raised the tally of Omicron patients found in the country’s financial capital to 15, including five who are from outside Mumbai.
But 13 of these patients have already been discharged from hospitals.
In fact, none of the 15 Omicron patients found in the city so far has reported severe symptoms, the BMC said.
The tally of Omicron patients in Maharashtra has reached 40.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
SC raps HP govt over denial of job to 2014 Asian Games gold winner
Kejriwal continues attack on Centre over law and order in Delhi ahead of assembly polls
LS, RS got adjourned due to govt’s continuing refusal to allow Oppn to raise Adani ‘scam’: Cong
Woman detained in Mumbai for call threatening PM Modi
Donald Trump ‘friend of India’: Minister Goyal
MUST WATCH
Latest Additions
SC raps HP govt over denial of job to 2014 Asian Games gold winner
Discussion on ‘Hybrid’ model for hosting Champions Trophy set to dominate ICC meeting
Kejriwal continues attack on Centre over law and order in Delhi ahead of assembly polls
There are talks regarding changing Karnataka Cong president, says Minister Parameshwara
LS, RS got adjourned due to govt’s continuing refusal to allow Oppn to raise Adani ‘scam’: Cong
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.